Product Details
Keywords
- Letrozole
- 112809-51-5
- Oncology
Quick Details
- ProName: Top Supplier Letrozole
- CasNo: 112809-51-5
- Molecular Formula: C17H11N5
- Appearance: White crystal powder
- Application: Used in the treatment of breast cancer...
- DeliveryTime: 3days
- PackAge: 10g/pack,100g/pack,1kg/pack
- Port: Shanghai port
- ProductionCapacity: 10000 Kilogram/Year
- Purity: 99%min
- Storage: storage in a dry, ventilated place und...
- Transportation: BY EMS,FEDEX,AIR
- LimitNum: 1 Gram
- Related Substances: ok
- Residue on Ignition: ok
- Heavy Metal: qualified
- Valid Period: 2years
- Batch: 20200409
Superiority
1.Product Name: letrozole
2.CAS NO: 112809-51-5
3.Appearance: White powder
4.letrozole Content: 99.9%
5.Molecular Formula: C17H11N5
Introduction
Letrozole is an oral non-steroidal inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Letrozole prevents the aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome p450 unit, the action is specific,and letrozol does not reduce production of mineralo-or corticosteroids.
Function and usage
Pyrrole type aromatization enzyme inhibitors. Used in the treatment of breast cancer.
Details
1.Product Name: letrozole
2.CAS NO: 112809-51-5
3.Appearance: White powder
4.letrozole Content: 99.9%
5.Molecular Formula: C17H11N5
Introduction
Letrozole is an oral non-steroidal inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Letrozole prevents the aromatase from producing estrogens by competitive, reversible binding to the heme of its cytochrome p450 unit, the action is specific,and letrozol does not reduce production of mineralo-or corticosteroids.
Function and usage
Pyrrole type aromatization enzyme inhibitors. Used in the treatment of breast cancer.
China (Mainland)
